- Home
- GLPG vs BWLP Comparison
GLPG vs BWLP Comparison
Compare GLPG & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- BWLP
- Stock Information
- Founded
- GLPG 1999
- BWLP 1935
- Country
- GLPG Belgium
- BWLP Singapore
- Employees
- GLPG N/A
- BWLP N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- BWLP Marine Transportation
- Sector
- GLPG Health Care
- BWLP Consumer Discretionary
- Exchange
- GLPG Nasdaq
- BWLP Nasdaq
- Market Cap
- GLPG 2.1B
- BWLP 2.4B
- IPO Year
- GLPG 2005
- BWLP N/A
- Fundamental
- Price
- GLPG $33.24
- BWLP $15.66
- Analyst Decision
- GLPG Sell
- BWLP
- Analyst Count
- GLPG 3
- BWLP 0
- Target Price
- GLPG $26.00
- BWLP N/A
- AVG Volume (30 Days)
- GLPG 162.5K
- BWLP 449.1K
- Earning Date
- GLPG 10-29-2025
- BWLP 08-26-2025
- Dividend Yield
- GLPG N/A
- BWLP 8.58%
- EPS Growth
- GLPG N/A
- BWLP N/A
- EPS
- GLPG N/A
- BWLP 1.50
- Revenue
- GLPG $323,674,692.00
- BWLP $3,554,740,000.00
- Revenue This Year
- GLPG $1.77
- BWLP N/A
- Revenue Next Year
- GLPG N/A
- BWLP $4.73
- P/E Ratio
- GLPG N/A
- BWLP $11.09
- Revenue Growth
- GLPG 5.43
- BWLP 1.27
- 52 Week Low
- GLPG $22.36
- BWLP $7.86
- 52 Week High
- GLPG $33.86
- BWLP $16.60
- Technical
- Relative Strength Index (RSI)
- GLPG 58.22
- BWLP 55.86
- Support Level
- GLPG $31.49
- BWLP $15.42
- Resistance Level
- GLPG $33.63
- BWLP $16.31
- Average True Range (ATR)
- GLPG 0.68
- BWLP 0.27
- MACD
- GLPG 0.01
- BWLP -0.05
- Stochastic Oscillator
- GLPG 85.82
- BWLP 50.38
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.